MONOCLONAL ANTIBODIES AGAINST TYPE I PHOSPHOLIPASE A2, USED AS A THERAPEUTIC AGENT TO REDUCE INFLAMMATION

The invention concerns the use of monoclonal antibodies against type I phospholipase A2? in the preparaton of a therapeutic agent to reduce inflammation. This agent is particularly suitable for use in cases of acute pancreatitis. L'invention concerne l'utilisation d'anticorps monoclon...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TIBES, ULRICH, HUEBNER-PARAJSZ, CHRISTA, SCHEUER, WERNER
Format:	Patent
Sprache:	eng ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention concerns the use of monoclonal antibodies against type I phospholipase A2? in the preparaton of a therapeutic agent to reduce inflammation. This agent is particularly suitable for use in cases of acute pancreatitis. L'invention concerne l'utilisation d'anticorps monoclonaux contre la phospholipase A2 de type I, pour la fabrication d'un agent thérapeutique inhibant l'inflammation, administré notamment dans les cas de pancréatite aiguë.